P. Bongioanni et G. Meucci, T-CELL TUMOR-NECROSIS-FACTOR-ALPHA RECEPTOR-BINDING IN PATIENTS WITH MULTIPLE-SCLEROSIS, Neurology, 48(4), 1997, pp. 826-831
MS is a T-cell-mediated demyelinating disease of the CNS, in which the
cytokine network may be deranged, leading to an altered immunoregulat
ion. Tumor necrosis factor alpha (TNF-alpha) is a cytokine with severa
l effects on the neuroimmune system. There are specific TNF-alpha rece
ptors on human lymphocytes and other cell types, even in the CNS. We a
ssayed TNF-alpha binding on peripheral blood T cells from MS patients
compared with healthy subjects. T cells from MS patients have signific
antly more TNF-alpha receptors than those from control subjects (B-max
, 955 +/- 31 versus 126 +/- 3 [mean +/- SEM] receptors per cell). Such
TNF-alpha binding sites are of the same type in patients and healthy
subjects (K-d, 68.7 +/- 4.8 versus 70.2 +/- 4.1 [mean +/- SEM] pM). We
discuss these results in terms of MS immunopathogenesis, because acti
vated T cells have increased amounts of TNF-alpha receptors.